Analyst
KeyBank
Equibles does not estimate personal net worth.
Paul Knight is recorded as Analyst at KeyBank. Paul Knight has spoken on 13 earnings calls across 7 companies, most recently for Aptargroup, Inc. on October 30, 2026. Those appearances were for Aptargroup, Inc. (ATR), Azenta, Inc. (AZTA), Avantor, Inc. (AVTR), Rapid Micro Biosystems, Inc. (RPID), Repligen Corp (RGEN) and 2 other companies. The companies whose calls Paul Knight spoke on are classified in the Healthcare sector.
“Evaluate pharma is to be blamed, which seems to be a credible source, of course. They're looking at a 14% growth rate in the top 10 intranasal drugs.”
“On the stores business where I think you mentioned it was going modular, it's probably hard to explain the engineering quickly, but is this kind of a step up in terms of simplicity and lower risk for what even pre- or tenure has been kind of an unpredictable performing product line?”
“Can you talk to the Millipore JV expansion by what, more services?”
“Are you having most success in auto-injector, pen, or a pre-filled syringe?”
KeyBank
Analyst
Transcript header (unverified)
ATR
Medical Instruments & Supplies · Healthcare
AZTA
Medical Instruments & Supplies · Healthcare
AVTR
Medical Instruments & Supplies · Healthcare
RGEN
Medical Instruments & Supplies · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
Medical Instruments & Supplies · Healthcare
